Health Insurance Innovations, Inc. (HIIQ) Shares Gap Down After Insider Selling

Cornelia Mascio
Settembre 13, 2017

(NASDAQ:ARWR), its shares were trading at $3.44 a gain of $0.01, on the trading floor. Shares for $488,300 were sold by Wang Sheldon on Thursday, May 4.

A number of research firms have issued reports on HIIQ. Analysts on average have given a price target of $38.67 to Health Insurance Innovations, Inc. stock.

Health Insurance Innovations, Inc. has its outstanding Shares of 16.72 Million. Zacks Investment Research raised shares of Health Insurance Innovations from a hold rating to a buy rating and set a $22.00 price target on the stock in a report on Friday, May 5th. TheStreet raised shares of Health Insurance Innovations from a "c" rating to a "b-" rating in a research report on Monday, May 22nd. The stock was sold at an average price of $26.68, for a total transaction of $800,400.00. One analyst has rated the stock with a hold rating and eight have issued a buy rating to the stock. Its last month's stock price volatility remained 17.42% which for the week stands at 8.7%. The relative volume of the stock is 16.88, while its market cap is $499.93 Million. Narrowing in, the stock is at a distance of -35.33% from the 50 day high and 18.06% off of the 50 day low. Health Insurance Innovations, Inc. has a 52-week low of 4.00 and a 52-week high of 37.38. 4783004 shares were traded on Health Insurance Innovations, Inc.'s last session. Shares of FTNT have uptrended 2.16% in the past three months, while the S&P 500 has moved -0.57% in that time. Health Insurance Innovations had a net margin of 5.56% and a return on equity of 22.89%. Taking the time to properly examine a company before purchasing shares may be the difference between healthy profits and disappointing losses. The business's quarterly revenue was up 38.9% on a year-over-year basis.

TRADEMARK VIOLATION WARNING: This piece was originally posted by Week Herald and is owned by of Week Herald. If you are reading this report on another website, it was stolen and reposted in violation of United States and worldwide copyright & trademark law. The shares were sold at an average price of $31.69, for a total transaction of $516,768.83. Furthermore on 3/13/17 Canaccord Genuity "Initiates Coverage On" the stock to Buy at $0. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Robert S. Murley bought 3,000 shares of the firm's stock in a transaction on Friday, September 1st. Over the past month the firm's stock is -24.56%, 10.40% for the last quarter, 38.99% for the past six-months and 354.28% for the previous year. On September 11, 2017, SeekingAlpha published an article asserting that in June 2017, the Company was rejected for a key insurance license in its home state of Florida, as the regulator uncovered undisclosed legal actions against Company insiders. The disclosure for this purchase can be found here. Navellier Assoc holds 0.07% or 24,678 shares. Renaissance Technologies LLC boosted its position in Health Insurance Innovations by 68.3% during the 2nd quarter. Craig Hallum began coverage on shares of Health Insurance Innovations in a research report on Monday, June 12th. Bank of New York Mellon Corp lifted its position in Health Insurance Innovations by 11.5% in the 1st quarter. Dialectic Capital Management LP now owns 496,300 shares of the financial services provider's stock worth $7,941,000 after acquiring an additional 141,083 shares during the period. Of the analysts surveyed by Reuters that track Health Insurance Innovations, Inc. Health Insurance Innovations Inc (NASDAQ:HIIQ) has risen 227.83% since September 12, 2016 and is uptrending. Hedge funds and other institutional investors own 90.32% of the company's stock.

Health Insurance Innovations, Inc is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Firm also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP.

To view ValuEngine's full report, visit ValuEngine's official website.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE